Skip to Content
Series

Bristol Myers Squibb CEO details promising acquisitions, healthcare message to Biden administration

January 27, 2021 19:18 PM UTC
- Updated April 15, 2021 05:54 AM UTC

Giovanni Caforio cites BMS’s medicine pipeline as strong financial asset.